Byhealth Dirección

Dirección controles de criterios 3/4

El CEO de Byhealth es Zhicheng Lin, nombrado en Sep 2014, tiene una permanencia de 10.17 años. posee directamente un 0.021% de las acciones de la empresa, con un valor de CN¥4.51M. La antigüedad media del equipo directivo y de la junta directiva es de 10.2 años y 5.4 años, respectivamente.

Información clave

Zhicheng Lin

Chief Executive Officer (CEO)

CN¥7.0m

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	10.2yrs
Participación del CEO	0.02%
Permanencia media de la dirección	10.2yrs
Promedio de permanencia en la Junta Directiva	5.4yrs

Actualizaciones recientes de la dirección

Recent updates

CEO

Zhicheng Lin (56 yo)

10.2yrs

Permanencia

CN¥7,000,300

Compensación

Mr. Zhicheng Lin has been Chief Executive Officer at Byhealth Co.,Ltd since September 26, 2014 and served as its Vice President and Secretary since June 2012 and since July 2012 respectively. Mr. Lin was D...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Zhicheng Lin	CEO & Non-Independent Director	10.2yrs	CN¥7.00m	0.021% CN¥ 4.5m
Jinyin Tang	Secretary to the Board of Directors	6.6yrs	CN¥1.04m	sin datos
Hong Chen	Deputy General Manager	16.2yrs	CN¥5.00m	1.05% CN¥ 229.2m
Liangping Cai	Deputy General Manager	10.2yrs	CN¥5.00m	0.032% CN¥ 6.9m

10.2yrs

Permanencia media

53yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de 300146 es experimentado (10.2 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Zhicheng Lin	CEO & Non-Independent Director	10.2yrs	CN¥7.00m	0.021% CN¥ 4.5m
Shuisheng Liang	Non-Independent Vice Chairman	16.2yrs	CN¥5.00m	1.02% CN¥ 222.3m
Yunchao Liang	Non-Independent Chairman of the Board	16.2yrs	CN¥604.40k	42.17% CN¥ 9.2b
Yu Ming Hu	Independent Director	1.3yrs	CN¥42.60k	sin datos
Hui Tang	Non-Independent Director	16.2yrs	CN¥8.26m	0.43% CN¥ 92.8m
Heng Liu	Independent Director	1.3yrs	CN¥42.60k	sin datos
Zhuoyi Wu	Chairman of the Supervisory Board	1.3yrs	CN¥1.80m	sin datos
Huizhen Shi	Member of Supervisory Board	6.7yrs	sin datos	sin datos
Chuanyuan Deng	Independent Director	4.2yrs	CN¥120.00k	sin datos
Le Li	Supervisor	2.8yrs	sin datos	sin datos

5.4yrs

Permanencia media

56yo

Promedio de edad

Junta con experiencia: La junta directiva de 300146 se considera experimentada (5.4 años de antigüedad promedio).

Byhealth Dirección

Dirección controles de criterios 3/4

Información clave

Actualizaciones recientes de la dirección

Byhealth Co., Ltd, Annual General Meeting, Apr 11, 2024

High number of new directors

Byhealth Co. Ltd. Approves Executive Appointments

By-health Co., Ltd., Annual General Meeting, Mar 26, 2021

By-health Co., Ltd. Announces Management Appointment

Recent updates

Third quarter 2024 earnings released: CN¥0.013 loss per share (vs CN¥0.21 profit in 3Q 2023)

Investor sentiment deteriorates as stock falls 17%

Byhealth Co., Ltd to Report Q3, 2024 Results on Oct 26, 2024

Investor sentiment improves as stock rises 17%

New minor risk - Earnings quality

Second quarter 2024 earnings released: EPS: CN¥0.095 (vs CN¥0.30 in 2Q 2023)

Byhealth Co., Ltd to Report First Half, 2024 Results on Aug 06, 2024

First quarter 2024 earnings released: EPS: CN¥0.43 (vs CN¥0.61 in 1Q 2023)

Dividend increased to CN¥0.90

Byhealth Co., Ltd Approves Cash Dividend for the Year 2023

Byhealth Co., Ltd to Report Q1, 2024 Results on Apr 26, 2024

Byhealth Co., Ltd Announces Profit Distribution Proposal for 2023

Byhealth Co., Ltd, Annual General Meeting, Apr 11, 2024

Full year 2023 earnings released: EPS: CN¥1.03 (vs CN¥0.82 in FY 2022)

Now 21% overvalued

Byhealth Co., Ltd to Report Fiscal Year 2023 Results on Mar 19, 2024

Third quarter 2023 earnings released: EPS: CN¥0.21 (vs CN¥0.25 in 3Q 2022)

Provexis plc Announces Byhealth Co., Ltd Regulatory Filing with Chinese SAMR

High number of new directors

Byhealth Co. Ltd. Approves Executive Appointments

Second quarter 2023 earnings released: EPS: CN¥0.30 (vs CN¥0.23 in 2Q 2022)

Byhealth Co., Ltd to Report First Half, 2023 Results on Aug 05, 2023

Full year 2022 earnings released: EPS: CN¥0.82 (vs CN¥1.06 in FY 2021)

Third quarter 2022 earnings released: EPS: CN¥0.25 (vs CN¥0.17 in 3Q 2021)

Second quarter 2022 earnings released

First quarter 2022 earnings released: EPS: CN¥0.39 (vs CN¥0.52 in 1Q 2021)

By-Health Co., Ltd. Implements Cash Dividend for 2021, Payable on 13 April 2022

By-Health Co., Ltd. Approves Cash Dividend for 2021

By-health Co., Ltd. Proposes Cash Dividend for 2021

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Third quarter 2021 earnings released: EPS CN¥0.17 (vs CN¥0.32 in 3Q 2020)

Investor sentiment deteriorated over the past week

First quarter 2021 earnings released: EPS CN¥0.52 (vs CN¥0.34 in 1Q 2020)

Investor sentiment improved over the past week

By-health Co., Ltd., Annual General Meeting, Mar 26, 2021

New 90-day high: CN¥28.08

Full year 2020 earnings released: EPS CN¥0.96 (vs CN¥0.24 loss in FY 2019)

Revenue misses expectations

New 90-day low: CN¥22.89

By-health Co., Ltd. to Report Fiscal Year 2020 Results on Mar 06, 2021

New 90-day high: CN¥25.87

Third quarter earnings released

By-health Co., Ltd. to Report Q3, 2020 Results on Oct 28, 2020

By-health Co., Ltd. Announces Management Appointment

New 90-day high - CN¥23.69

By-health Co., Ltd. to Report First Half, 2020 Results on Jul 30, 2020

CEO

Permanencia

Compensación

Equipo directivo

Permanencia media

Promedio de edad

Miembros de la Junta

Permanencia media

Promedio de edad